BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 27702699)

  • 1. Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.
    Bose S; Cho J
    Ageing Res Rev; 2017 May; 35():155-175. PubMed ID: 27702699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control of the proteins associated with neurodegenerative diseases.
    Gao X; Hu H
    Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):612-8. PubMed ID: 18604452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
    Luo GR; Le WD
    Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
    Dohm CP; Kermer P; Bähr M
    Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein folding and misfolding in the neurodegenerative disorders: a review.
    Bolshette NB; Thakur KK; Bidkar AP; Trandafir C; Kumar P; Gogoi R
    Rev Neurol (Paris); 2014 Mar; 170(3):151-61. PubMed ID: 24613386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Chaperones in Neurodegenerative Diseases: A Short Review.
    Bobori C; Theocharopoulou G; Vlamos P
    Adv Exp Med Biol; 2017; 987():219-231. PubMed ID: 28971461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular chaperones biochemistry and role in neurodegenerative diseases.
    Chaari A
    Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.
    Bohush A; Bieganowski P; Filipek A
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
    Maiti P; Manna J; Veleri S; Frautschy S
    Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteostasis in neurodegenerative diseases.
    Kinger S; Jagtap YA; Kumar P; Choudhary A; Prasad A; Prajapati VK; Kumar A; Mehta G; Mishra A
    Adv Clin Chem; 2024; 121():270-333. PubMed ID: 38797543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders.
    Di Domenico F; Lanzillotta C
    Adv Protein Chem Struct Biol; 2022; 132():49-87. PubMed ID: 36088079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging.
    Hinault MP; Ben-Zvi A; Goloubinoff P
    J Mol Neurosci; 2006; 30(3):249-65. PubMed ID: 17401151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications.
    Adachi H; Katsuno M; Waza M; Minamiyama M; Tanaka F; Sobue G
    Int J Hyperthermia; 2009 Dec; 25(8):647-54. PubMed ID: 20021225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
    Muchowski PJ
    Neuron; 2002 Jul; 35(1):9-12. PubMed ID: 12123602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein quality control in neurodegenerative disease.
    Gestwicki JE; Garza D
    Prog Mol Biol Transl Sci; 2012; 107():327-53. PubMed ID: 22482455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of the proteasomal system with chaperones: protein triage and protein quality control.
    Kästle M; Grune T
    Prog Mol Biol Transl Sci; 2012; 109():113-60. PubMed ID: 22727421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.